Tag: AstraZeneca
Cann Group names Peter Koetsier as new CEO
Cann Group, a leading manufacturer and supplier of innovative cannabis medicines, appointed Peter Koetsier as its new chief executive officer, effective 16 January 2023.
AstraZeneca backs LBT Innovations’ drug manufacturing AI development
LBT Innovations has partnered with AstraZeneca to develop artificial intelligence software that would be used in drug manufacturing.
Government should invest in Australia’s vaccine manufacturing capability – The Greens
In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country.
The...
AstraZeneca enlists Germany’s IDT to meet COVID-19 jab demand in the EU
AstraZeneca and IDT Biologika's joint investment will boost vaccine manufacturing capability and address jab shortages in Europe.
Leading coronavirus vaccine maker AstraZeneca announced yesterday that...
CSL commences manufacture of University of Oxford /AstraZeneca vaccine candidate
CSL has announced it will commence manufacturing the University of Oxford/AstraZeneca AZD1222 COVID-19 vaccine candidate on Monday 9th November.
The global biotech company has separate...
CSL inks final agreement to manufacture UQ COVID-19 vaccine candidate
CSL‘s subsidiary, Seqirus, has signed a final agreement with the Federal Government for the supply of 51 million doses of the University of Queensland-CSL...
CSL to manufacture and supply two COVID-19 vaccine candidates for Australia
The Australian Government has signed an agreement with CSL under which the global biotech company will supply 51 million doses of the University of...
Starpharma inks second deal with global pharmaceutical giant
Australian company Starpharma has signed a milestone deal with global pharmaceutical giant AstraZeneca to further develop a Dendrimer Enhanced Product (DEP) version of one...
AstraZeneca to expand its manufacturing facility in Sydney
Global biopharmaceutical business AstraZeneca has announced a $100 million expansion of its Sydney manufacturing facility aimed at boosting its exports to the growing Chinese...
AstraZeneca rejects Pfizer’s final takeover offer
AstraZeneca, one of the world’s leading pharmaceutical and biologics companies, has rejected Pfizer’s improved and “final” offer for a merger that would have created...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
